Doctor of Osteopathy Program year 2023 Reported 2020–2023 Source: CMS Open Payments, 2026 publication

Brandon Kukor

Psychiatry Henderson, NV Doctor of Osteopathy

NPI 1528473980 CMS profile 776997

2831 Saint Rose Pkwy Ste 222, Henderson, NV 89052

Open in the dashboard

General payments

$137

2 records reported · program years 2020–2023

Research payments

$0

Paid to them · None reported · program years 2020–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Brandon Kukor of Henderson, NV is reported in the CMS Open Payments database as having received $137 across 2 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 36th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $18 1
2020 General $119 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brandon Kukor
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Brandon Kukor were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Brandon Kukor Psychiatry median Middle half National median
2019 $0 $184 $59–$605 $163
2020 $119 $119 $36–$372 $114
2021 $0 $143 $43–$576 $132
2022 $0 $153 $50–$590 $149
2023 $18 $170 $56–$651 $160
2024 $0 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2020–2023
  1. ACADIA Pharmaceuticals Inc $119 1 payment
  2. Otsuka America Pharmaceutical, Inc. $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2023
  1. Food and Beverage $137 2 payments
Products named General payments · program years 2020–2023
  1. NUPLAZID $119 1 payment
  2. NUEDEXTA $18 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

769

Median for Psychiatry: 574

Drug cost

$19,912

Median for Psychiatry: $27,624

Branded share of claims

0%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Aripiprazole Generic 24 $2,803
Mirtazapine Generic 69 $2,172
Duloxetine Hcl Generic 46 $2,144
Trazodone Hcl Generic 88 $1,773
Doxepin Hcl Generic 14 $1,557
Sertraline Hcl Generic 77 $1,233
Divalproex Sodium Generic 46 $1,232
Hydroxyzine Hcl Generic 74 $1,145
Escitalopram Oxalate Generic 58 $958
Risperidone Generic 42 $924

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 7 billing codes

Paid by Medicare

$132,305

Medicare's payments for the services billed

Medicare patients

689

Average age 74

Services billed

2,105

410 women, 279 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Depression 75%
Alzheimer's or dementia 60%
Diabetes 48%
Arthritis 37%
COPD 36%
Chronic kidney disease 35%
Heart failure 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

2 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record